Legend Biotech Corporation (LEGN) Debt by Year
Legend Biotech Corporation carried $87.2M in long-term debt against $901.9M in cash and equivalents at the end of fiscal year 2025. This represents an increase of 95.5% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Legend Biotech Corporation has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
LEGN Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
LEGN Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q3'256-K | Q2'256-K | Q1'2510-Q | Q4'2420-F | Q3'246-K | Q2'246-K | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $87.2M+95.5% | $88.1M+93.0% | $71.7M+62.9% | $51.7M+14.5% | $44.6M+1.0% | $45.6M+9.4% | $44.0M-0.9% | $45.2M | $44.2M+120.4% | $41.7M-31.1% | $44.4M-27.0% | N/A |
| Cash & Equivalents | $901.9M+214.6% | $278.9M-39.3% | $266.6M+32.5% | $441.7M-50.8% | $286.7M-77.6% | $459.3M-52.3% | $201.3M-83.7% | $897.6M+36.0% | $1.3B+62.6% | $963.5M+18.5% | $1.2B+224.7% | $660.0M |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Legend Biotech Corporation financials
Frequently Asked Questions
What was Legend Biotech Corporation's long-term debt in fiscal year 2025?
Legend Biotech Corporation carried $87.2M in long-term debt against $901.9M in cash and equivalents at the end of fiscal year 2025.
How fast is Legend Biotech Corporation's long-term debt growing?
Legend Biotech Corporation (LEGN) long-term debt rose by 95.5% year over year, from $44.6M to $87.2M in fiscal year 2025.
What was Legend Biotech Corporation's long-term debt in the most recent quarter?
Legend Biotech Corporation (LEGN) reported $87.2M in long-term debt in Q4 2025. This represents an increase of 95.5% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Legend Biotech Corporation (LEGN) reported on that line in every period on record.